Accueil   Diary - News   All news Poxel announces patent access agreement with ENYO

Poxel announces patent access agreement with ENYO

Second agreement signed with Enyo for FXR Technology in infectious diseases

 

POXEL SA announced a second agreement with ENYO Pharma SA, by wich Enyo accesses a key patent on the use of FXR technology to develop treatments for Hepatitis B.

 

Read the press release

 

 

 

 

 

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree